2b0u

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="2b0u" size="450" color="white" frame="true" align="right" spinBox="true" caption="2b0u, resolution 2.800&Aring;" /> '''The Structure of t...)
Line 1: Line 1:
-
[[Image:2b0u.gif|left|200px]]<br />
+
[[Image:2b0u.gif|left|200px]]<br /><applet load="2b0u" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="2b0u" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="2b0u, resolution 2.800&Aring;" />
caption="2b0u, resolution 2.800&Aring;" />
'''The Structure of the Follistatin:Activin Complex'''<br />
'''The Structure of the Follistatin:Activin Complex'''<br />
==Overview==
==Overview==
-
TGF-beta ligands stimulate diverse cellular differentiation and growth, responses by signaling through type I and II receptors. Ligand, antagonists, such as follistatin, block signaling and are essential, regulators of physiological responses. Here we report the structure of, activin A, a TGF-beta ligand, bound to the high-affinity antagonist, follistatin. Two follistatin molecules encircle activin, neutralizing the, ligand by burying one-third of its residues and its receptor binding, sites. Previous studies have suggested that type I receptor binding would, not be blocked by follistatin, but the crystal structure reveals that the, follistatin N-terminal domain has an unexpected fold that mimics a, universal type I receptor motif and occupies this receptor binding site., The formation of follistatin:BMP:type I receptor complexes can be, explained by the stoichiometric and geometric arrangement of the, activin:follistatin complex. The mode of ligand binding by follistatin has, important implications for its ability to neutralize homo- and, heterodimeric ligands of this growth factor family.
+
TGF-beta ligands stimulate diverse cellular differentiation and growth responses by signaling through type I and II receptors. Ligand antagonists, such as follistatin, block signaling and are essential regulators of physiological responses. Here we report the structure of activin A, a TGF-beta ligand, bound to the high-affinity antagonist follistatin. Two follistatin molecules encircle activin, neutralizing the ligand by burying one-third of its residues and its receptor binding sites. Previous studies have suggested that type I receptor binding would not be blocked by follistatin, but the crystal structure reveals that the follistatin N-terminal domain has an unexpected fold that mimics a universal type I receptor motif and occupies this receptor binding site. The formation of follistatin:BMP:type I receptor complexes can be explained by the stoichiometric and geometric arrangement of the activin:follistatin complex. The mode of ligand binding by follistatin has important implications for its ability to neutralize homo- and heterodimeric ligands of this growth factor family.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
2B0U is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with IR3, MLI and MPD as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2B0U OCA].
+
2B0U is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=IR3:'>IR3</scene>, <scene name='pdbligand=MLI:'>MLI</scene> and <scene name='pdbligand=MPD:'>MPD</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2B0U OCA].
==Reference==
==Reference==
Line 17: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Cook, R.W.]]
+
[[Category: Cook, R W.]]
-
[[Category: Jardetzky, T.S.]]
+
[[Category: Jardetzky, T S.]]
-
[[Category: Lerch, T.F.]]
+
[[Category: Lerch, T F.]]
-
[[Category: Thompson, T.B.]]
+
[[Category: Thompson, T B.]]
-
[[Category: Woodruff, T.K.]]
+
[[Category: Woodruff, T K.]]
[[Category: IR3]]
[[Category: IR3]]
[[Category: MLI]]
[[Category: MLI]]
Line 31: Line 30:
[[Category: tgf-beta]]
[[Category: tgf-beta]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:56:54 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:33:02 2008''

Revision as of 14:33, 21 February 2008


2b0u, resolution 2.800Å

Drag the structure with the mouse to rotate

The Structure of the Follistatin:Activin Complex

Contents

Overview

TGF-beta ligands stimulate diverse cellular differentiation and growth responses by signaling through type I and II receptors. Ligand antagonists, such as follistatin, block signaling and are essential regulators of physiological responses. Here we report the structure of activin A, a TGF-beta ligand, bound to the high-affinity antagonist follistatin. Two follistatin molecules encircle activin, neutralizing the ligand by burying one-third of its residues and its receptor binding sites. Previous studies have suggested that type I receptor binding would not be blocked by follistatin, but the crystal structure reveals that the follistatin N-terminal domain has an unexpected fold that mimics a universal type I receptor motif and occupies this receptor binding site. The formation of follistatin:BMP:type I receptor complexes can be explained by the stoichiometric and geometric arrangement of the activin:follistatin complex. The mode of ligand binding by follistatin has important implications for its ability to neutralize homo- and heterodimeric ligands of this growth factor family.

Disease

Known disease associated with this structure: Polycystic ovary syndrome OMIM:[136470]

About this Structure

2B0U is a Protein complex structure of sequences from Homo sapiens with , and as ligands. Full crystallographic information is available from OCA.

Reference

The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding., Thompson TB, Lerch TF, Cook RW, Woodruff TK, Jardetzky TS, Dev Cell. 2005 Oct;9(4):535-43. PMID:16198295

Page seeded by OCA on Thu Feb 21 16:33:02 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools